AstraZeneca Wang Lei: Continue to increase investment in research and development and medical innovation in China
阿豆学长长ov
发表于 2023-11-5 17:09:09
255
0
0
Wang Lei, Global Executive Vice President and President of International Business and China at AstraZeneca, stated that over the past five years, relying on the advantages of China's large market, CIIE has made positive contributions to accelerating the construction of a new development pattern and promoting world economic development. Through the CIIE, AstraZeneca deeply felt the signal of China's adherence to opening-up and continued support for economic globalization, as well as its responsible image as a major country.
Wang Lei stated that AstraZeneca, as an old friend of CIIE, has participated in six consecutive exhibitions this year. Relying on the strong influence and spillover effects of the CIIE platform, AstraZeneca will announce the latest progress in investment in China at this CIIE, continue to increase investment in China, including research and development, medical innovation, and promote production and supply layout. AstraZeneca will also work with cross-border partners to continuously assist Chinese enterprises and innovative achievements in accelerating their "going global" journey, creating a "global new" with "China's new" approach, promoting the sustainable development of healthcare and contributing to the cause of human health.
Wang Lei stated that history has proven that the Chinese economy is a very stable development ship, and China is one of the largest markets in the world. AstraZeneca will use a more determined belief to play a role as a link and bridge, deepening its long-term commitment to "rooted in China, serving China, and benefiting the world".
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Gilead Science's second HIV pre exposure prophylactic drug has been approved in China, and the awareness rate of PrEP in China is still relatively low
- The big news of "weight loss miracle drug"! Oral Smegglutide Approved for Market in China
- Industry shock! Alibaba Cloud suddenly announced the largest price reduction in history!
- Continuously focusing on content and increasing AI investment in iQiyi's current year
- Novo Nordisk's new weight loss oral medication is applying for clinical efficacy or surpassing smeglutide in China
- How effective is the drug supply process initiated by Novo Nordisk for the approved slimming version of Smegglutide in China?
- "Weight loss pills" are sold in limited quantities in China? Novo Nordisk's latest response
- Yizi International expands its business in China and adds equity investment in Enxi Village
- Yizi International further expands its business in China and significantly increases its equity investment in Enxi Village
- Yizi International further expands its business in China and significantly increases its equity investment in Enxi Village
-
【科技记者古尔曼:苹果计划于12月第一周发布iOS 18.2系统更新 带来更多人工智能功能】科技记者古尔曼透露,苹果计划于12月第一周发布iOS 18.2系统更新。iOS 18.2将为iPhone 15 Pro机型和所有iPhone 16机型带来更多 ...
- cristianna
- 昨天 17:32
- 支持
- 反对
- 回复
- 收藏
-
近日,爱立信中国区总裁方迎在接受《经济参考报》记者采访时表示,5G技术在全球范围内得到了迅速发展,但面临商业潜力未能充分挖掘、网络运营难度较以往更高两大挑战。因此,运营商在继续5G网络部署的同时,应关 ...
- blueskybb
- 昨天 15:05
- 支持
- 反对
- 回复
- 收藏
-
【特斯拉首次聘请了一位品牌大使】特斯拉近日公布了首位品牌大使韩国奥运射击选手金艺智,这一举动有些出人意料,毕竟它曾经对广告的态度十分不屑。 ...
- xyyg
- 昨天 13:34
- 支持
- 反对
- 回复
- 收藏
-
证券时报网讯,纽约州共同退休基金在第三季度对一些科技巨头的股票进行了调整。该基金是美国第三大公共养老金,管理着2677亿美元的资产。该基金三季度出售了231,600股Palantir 股票,将其持股数量降至110万股。 ...
- LEMONKEITH
- 昨天 15:12
- 支持
- 反对
- 回复
- 收藏